Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709820013 | Eprosartan- and hydrochlorothiazide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3709821012 | Product containing eprosartan and hydrochlorothiazide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Has active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 1 | |
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Is a | Product containing eprosartan and hydrochlorothiazide (medicinal product) | true | Inferred relationship | Some | ||
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Is a | Hydrochlorothiazide-containing product in oral dose form | true | Inferred relationship | Some | ||
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Is a | Product containing eprosartan in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Has active ingredient | Eprosartan (substance) | true | Inferred relationship | Some | 2 | |
| Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Plays role | Diuretic therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Inferred relationship | Some | |
| Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Inferred relationship | Some | |
| Eprosartan and hydrochlorothiazide only product in oral dose form | Is a | True | Eprosartan- and hydrochlorothiazide-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR